Publications by authors named "E W Huber"

Neonatal brain injury remains a significant issue with limited treatment options. This study investigates the potential of the endogenous neurosteroid dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) as neuroprotective agents, building on evidence of their mechanisms in adult brain injury models. The primary objective was to evaluate their neuroprotective and anti-oxidative properties in a mouse model of neonatal hypoxic-ischemic brain injury.

View Article and Find Full Text PDF

Background: Burdening health and illness issues such as physical or mental illnesses, accidents, disabilities, and life events such as birth or death influence the health and functioning of families and contribute to the complexity of care and health care costs. Considerable research has confirmed the benefits of a family systems-centered care approach for patients, family caregivers, families, and health care professionals. However, health care professionals face barriers in working with families, such as feeling unprepared.

View Article and Find Full Text PDF

Context: Staging and monitoring of pre-symptomatic type 1 diabetes includes the assessment for dysglycemia.

Objective: To assess the ability of Continuous Glucose Monitoring (CGM) to differentiate between islet autoantibody-negative controls and early-stage type 1 diabetes and explore whether CGM classifiers predict progression to clinical diabetes.

Research Design And Methods: Children and adolescents participating in public health screening for islet autoantibodies in Bavaria, Germany were invited to undergo CGM with Dexcom G6.

View Article and Find Full Text PDF
Article Synopsis
  • Standard information reporting is essential for consistent assay conditions and data, enabling easier comparisons between laboratories.
  • The publication presents the Minimum Information for Reporting on the TEER assay (MIRTA), a key method used to assess cell culture models and toxicity potential.
  • Developed through an international collaboration, the recommendations from the RespTox Collaborative aim to improve data transparency, reproducibility, and quality in both respiratory and other cell systems.
View Article and Find Full Text PDF
Article Synopsis
  • - The study examines how secondary genetic variants can influence the clinical features of individuals with primary disease-causing variants, suggesting that these modifiers play a significant role in disease expression.
  • - Specifically focusing on the 16p12.1 deletion, researchers identified various rare and common variants that predisposed individuals to specific developmental issues, such as neurological defects and microcephaly.
  • - By analyzing data from different cohorts, the findings indicate that the effects of primary and secondary variants on phenotype vary depending on the specific primary variant involved, highlighting the need for personalized approaches in treatment.
View Article and Find Full Text PDF